Literature DB >> 20335574

Evolving data about subtrochanteric fractures and bisphosphonates.

Elizabeth Shane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20335574     DOI： 10.1056/NEJMe1003064

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  Update in new medications for primary care.

Authors:  Gerald W Smetana; Jane S Sillman
Journal:  J Gen Intern Med       Date:  2010-11-23       Impact factor: 5.128

Review 2.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

3.  Atypical diaphyseal femoral fractures--new aspects.

Authors:  Frieda Feldman
Journal:  Skeletal Radiol       Date:  2011-03-04       Impact factor: 2.199

4.  Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.

Authors:  Michael B Banffy; Mark S Vrahas; John E Ready; John A Abraham
Journal:  Clin Orthop Relat Res       Date:  2011-02-25       Impact factor: 4.176

5.  Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.

Authors:  H P Bögl; P Aspenberg; J Schilcher
Journal:  Osteoporos Int       Date:  2017-05-04       Impact factor: 4.507

Review 6.  Bone structural components regulating sites of tumor metastasis.

Authors:  Julie A Sterling; Scott A Guelcher
Journal:  Curr Osteoporos Rep       Date:  2011-06       Impact factor: 5.096

7.  Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs.

Authors:  David B Burr; Ziyue Liu; Matthew R Allen
Journal:  Bone       Date:  2014-10-23       Impact factor: 4.398

Review 8.  Proximal femoral fractures: Principles of management and review of literature.

Authors:  Ravi Mittal; Sumit Banerjee
Journal:  J Clin Orthop Trauma       Date:  2012-06-16

9.  A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial.

Authors:  Ighovwerha Ofotokun; Kehmia Titanji; Cecile D Lahiri; Aswani Vunnava; Antonina Foster; Sara E Sanford; Anandi N Sheth; Jeffrey L Lennox; Andrea Knezevic; Laura Ward; Kirk A Easley; Philip Powers; M Neale Weitzmann
Journal:  Clin Infect Dis       Date:  2016-05-18       Impact factor: 9.079

Review 10.  Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Authors:  Jacques P Brown; Suzanne Morin; William Leslie; Alexandra Papaioannou; Angela M Cheung; Kenneth S Davison; David Goltzman; David Arthur Hanley; Anthony Hodsman; Robert Josse; Algis Jovaisas; Angela Juby; Stephanie Kaiser; Andrew Karaplis; David Kendler; Aliya Khan; Daniel Ngui; Wojciech Olszynski; Louis-Georges Ste-Marie; Jonathan Adachi
Journal:  Can Fam Physician       Date:  2014-04       Impact factor: 3.275
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.